Neuphoria Therapeutics Board Extends Rights Agreement to October 27, 2027

• Neuphoria Therapeutics’ board entered into an amendment to its Rights Agreement on October 23, 2026.
• The amendment extends the agreement’s final expiration to close of business October 27, 2027, unless earlier extended, modified or terminated.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuphoria Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-111863), on October 23, 2026, and is solely responsible for the information contained therein.